Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • COP vs MRNA✓SelectedUSD · MRNACOP vs MRNA performance historyLatest closeAs of-3.64%11/18
Stock and ETF performance explorer

COP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+167.1%
MRNA return
+794.5%
Excess return
-627.4%
Maximum drawdown
-67.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.6%-4.8%+1.2%-3.6%
7D-1.9%-20.9%+19.0%-1.9%
30D-6.9%-13.3%+6.4%-6.9%
3M+4.3%+212.6%-208.3%+3.6%
6M+9.4%+309.0%-299.7%+8.4%
YTD+47.7%+567.3%-519.6%+45.5%
1Y+54.2%+689.7%-635.5%+51.5%
3Y+28.3%+157.4%-129.1%+26.2%
5Y+120.8%-21.7%+142.5%+115.9%
All+167.1%+794.5%-627.4%+153.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling